πŸ‡ΊπŸ‡Έ FDA
Patent

US 7816131

Cancer specific promoters

granted A61PA61P35/00

Quick answer

US patent 7816131 (Cancer specific promoters) held by The Board of Regents of the University of Texas System expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00